Anaveon AG

Swiss Biotech Association

Member

Anaveon is a late pre-clinical phase biotech based in Basel, Switzerland. It focuses on the development of next generation IL-2 based therapeutic antibodies for tumor immunotherapy in melanoma, kidney carcinoma and lung cancer.

Products, services, technology

ANV419

Location

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2017
Number of employees in Switzerland

10-19

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

Perseo pharma AG

Perseo pharma: best-in-class enzyme therapeutics Perseo pharma is a preclinical-stage biotech start-up…

0764231229
Hochbergerstrasse 60C, 4057 Basel, Switzerland

Member

OM Pharma Ltd

OM Pharma is the Geneva-based Biotech unit of Vifor Pharma. It develops and manufactures a unique portfolio…

Rue du Bois-du-Lan 22, 1217 Meyrin, Switzerland

Member

Vifor Pharma Management Ltd.

Vifor Pharma Group is a global pharmaceutical company. It aims to become the leader in iron deficiency,…

+41 58 851 80 00
Flughofstrasse 61, Glattbrugg, Switzerland

Member